Plenary Line Up
The daily plenary sessions feature some of the world’s most distinguished HIV scientists, policy specialists and community leaders. Plenary sessions bring all conference delegates together at the first session of every morning.
Plenary speakers will speak within a theme for each day (presentation titles are subject to change).
Tuesday, July 19 2016 - Day 1: Where are we now?
Global Epidemiology: State of the Pandemic
Steffanie Strathdee, United States
Dr Steffanie Strathdee, PhD, is the Associate Dean of Global Health Sciences, Harold Simon Professor and Chief of the Division of Global Public Health in the Department of Medicine at the University of California San Diego School of Medicine. She is also an Adjunct Professor at the Johns Hopkins University. Dr Strathdee is an infectious disease epidemiologist who has spent the last two decades focusing on HIV prevention in underserved, marginalised populations in developed and developing countries, including injection drug users, men having sex with men, and sex workers.
Implications of Gender on the Response
Elizabeth Anne Bukusi, Kenya
Dr Elizabeth Bukusi, MBChB, MMed (OBGyn), MPH, PhD, MBE, is the Co-Director of the KEMRI-UCSF Research Training Programme. She is a Chief Research Officer at the Centre for Microbiology Research and Deputy Director at the Kenyan Medical Research Institute (KEMRI) and an Honorary Lecturer for the University of Nairobi and Aga Khan University in Pakistan. She is faculty at the University of Washington in the Global Women’s Health Department of Obstetrics and Gynaecology and holds a volunteer faculty position at the University of California San Francisco (UCSF). Dr Bukusi has over twenty years of experience conducting research in HIV prevention, care and treatment, and building capacity for research in Kenya. Her research focuses on development of HIV prevention technologies, HIV care and treatment, and developing systems for improving research regulation and ethics in research.
Maurine Murenga, Kenya
Maurine has openly been living with HIV since the early 2000s. In 2002, she could not access Prevention of Mother to Child Transmission (PMTCT) services and her son contracted HIV from her at birth. Maurine and her son both began free treatment in 2003 when the Global Fund came to Kenya. In 2008, Maurine founded the Lean On Me Foundation, which provides comprehensive care and support to adolescent girls and young women living with HIV and tuberculosis in Kenya. Maurine was also a Global Fund Advocates Network ‘Here I Am’ Campaign Ambassador from 2012-2013. She currently works as the Global Fund Coordinator for the International Community of Women Living with HIV (ICW Global) and is a member of the Gender Technical Committee on HIV and AIDS in Kenya, Women4GF and the Communities Delegation to the Global Fund Board. Maurine is a two-time award winner for her work with women and girls - winning the Unsung Hero Award from the US embassy in Kenya and the East Africa Community Service Award from the Ufadhili Trust. Maurine has since had another baby in 2013 who is HIV-free.
Universal Access: Systems for Health in the Immediate Treatment Era
Alex Coutinho, Uganda
Dr Alex Coutinho recently retired as the Executive Director of Uganda’s Infectious Diseases Institute (IDI) and has spent three decades fighting HIV/AIDS in Africa. He is now working with Accordia Global Health Foundation and its implementing partners to increase Ebola preparedness and to advocate for structural changes to prevent such catastrophic outbreaks. Coutinho has held numerous leadership positions in global health. Currently, he chairs the Board of the International AIDS Vaccine Initiative (IAVI). He has served as Vice-Chair of the Global Fund Technical Review and Chair of the Board of the International Partnership for Microbicides.
Jonathan Mann Lecture: Protecting Human Rights and Reducing Stigma
Edwin Cameron, South Africa
Constitutional Court Judge Edwin Cameron discovered he was HIV positive in 1986 and has been described by Nelson Mandela as ‘one of South Africa’s new heroes’. He previously served as a judge on the Supreme Court of Appeal of South Africa and was the first senior South African official to state publicly that he was living with HIV/AIDS. A prominent human rights lawyer during apartheid, he has worked to safeguard human rights (including the rights of gays and lesbians) in the new constitution of South Africa. Cameron is also an accomplished author and has previously been a keynote speaker at the 13th International AIDS Conference in 2000 in Durban, South Africa.
Wednesday 20 July - Day 2: What is our goal?
Prevention Equity: Uptake of Innovations in Testing, Prevention, Reducing Incidence
Nittaya Phanuphak, Thailand
Dr Nittaya Phanuphak is an HIV dermatologist with extensive experience in HIV clinical trials, specialising in HIV prevention and sexual health. Currently Chief of the Prevention Department at the Thai Red Cross AIDS Research Centre, Dr Phanuphak has a broad expertise in conducting large clinical trials involving local and international collaborators and stakeholders. She started the country’s first Test and Treat study among Thai men who have sex with men (MSM) and transgender women in 2012. The study has evolved into a community-led model and PrEP study that has enrolled 6,000 MSM, male sex workers and transgender women in 2015. Dr Phanuphak has more than 60 publications in peer-reviewed journals.
TB and Co-Infections, Co-Morbidities: The Long Game
Anton Pozniak, United Kingdom
Dr Anton Pozniak ran the HIV research unit at King’s College, London before moving to his current position as Consultant Physician/Senior Lecturer at Chelsea and Westminster Hospital in 1998, where he is an Executive Director of HIV Research and the Director of HIV Services. He became a fellow of the Royal College of Physicians in 1996 and has been made a life member of the British HIV Association. Dr Pozniak was an advisor on HIV and AIDS to the UK Government Health Select Committee and is on the Expert Advisory Group on AIDS for the UK Department of Health. He is an Executive Member of the European AIDS Clinical Society and on the Governing Council of the International AIDS Society.
Toward an HIV Vaccine
Larry Corey, United States
Dr Larry Corey has led some of the most significant advances in medicine in the last 30 years, including the development of safe and effective antivirals for herpes viruses and HIV infections. As former President and Director of the Fred Hutchinson Cancer Research Center, he helped drive lifesaving discoveries across an even broader spectrum of diseases. Dr Corey is currently a Principal Investigator of the Fred Hutch-based HIV Vaccine Trials Network, the largest international effort dedicated to developing an HIV vaccine. Besides his appointment at the Fred Hutchinson Cancer Research Center, he is currently a Professor of Medicine and Laboratory Medicine at the University of Washington.
Youth Focus: Adolescents at Risk and in the Lead
Tariro Makadzange, Zimbabwe
Dr Tariro Makadzange is a physician scientist whose research focuses on perinatally HIV-infected children and adolescents, as well as HIV-positive adults with cryptococcal disease. An Instructor of Medicine at the Harvard Medical School and at the Ragon Institute of MGH, MIT and Harvard, Dr Makadzange is also an Assistant in Medicine at the Massachusetts General Hospital and a lecturer at the University of Zimbabwe College of Health Sciences. She is also a Consultant Physician and the Co-director of the Family Care Centre at the Parirenyatwa Hospital, which is one of the largest public HIV treatment centres for children and adults living with HIV in Zimbabwe.
Michael Ighodaro, Nigeria
Michael Ighodaro is a Nigerian activist and a passionate advocate for LGBTQ rights and HIV prevention. Michael had to flee his country after he was attacked due to his sexual orientation, work in HIV prevention and gay activism. Openly living with HIV himself, he is currently the Programme and Policy Assistant for AVAC, an organisation that advocates for HIV prevention to end AIDS. In response to the anti-homosexual law passed by Former President Goodluck Johnathan, Michael helped organise a Global Day of Action in protest of this law, which was also staged in front of Nigerian consulates in many cities all over the world. He has also worked with Housing Works and the International Gay and Lesbian Human Rights Commission (now Out Right Action) in New York. Michael is a member of several HIV/LGBT advocacy groups in Africa. He has spoken before the United Nations, the US Congress and State Department. In 2015, Michael was honoured as a White House Champion of Change for World Refugees. His work has appeared in the Huffington Post, Buzzfeed, New York Times and several UN news outlets. Michael is currently a student at The American Public University.
Thursday 21 July - Day 3: What are the key barriers?
Expanding Access for All at Risk and in Need
Cyriaque Ako, Ivory Coast
Diagnosed HIV-positive in 1992, Cyriaque Ako is a well-known HIV and human rights activist. He helped create the first HIV and men who have sex with men association in the Ivory Coast, known as Ruban Rouge CI and Arc En Ciel Plus. He also helped form regional and international organisations, such as the Pan African Treatment Access Movement (PATAM) and the International Treatment Preparedness Coalition (ITPC). He is an advocate for the rights of people living with HIV and sexual minorities, as well as for the scale up of access to HIV prevention, treatment, care and support of HIV. He previously served as the Executive Director of the Ivorian Network of People Living with HIV (RIP+) and has worked as a Program Coordinator for African Men for Sexual Health and Rights (AMSHeR). He is currently spearheading a project called Génération HSH sans sida (GHS) in five West and Central francophone African countries for the African Council of AIDS Service Organizations (AfriCASO). He is also the Acting Executive Secretary of the International Centre for Humanitarian Actions Networking and Grassroots Empowerment (ICHANGE CI). ICHANGE CI’s work focuses on transferring knowledge and skills to communities and beneficiaries with the aim to enhance their leadership, ownership and sustainability.
Barriers to a Cure
Deborah Persaud, United States
A clinician and researcher specialising in the study and treatment of HIV-1 infection in children, Dr Deborah Persaud is a Professor of Paediatrics at the Johns Hopkins Children’s Center. Time Magazine named Dr Persaud as one of the world’s 100 most influential people for 2013 after herself and colleagues announced the first functional cure of HIV in an infant. She has been active in the field of paediatric HIV latency for almost two decades and her research has focused on understanding the pathogenesis of HIV persistence in children and young people. She leads the HIV Cure Scientific Committee for the NIH-sponsored International Maternal Pediatric Adolescent AIDS Clinical Trials Network (IMPAACT), which focuses on virus eradication towards a remission and cure for paediatric populations.
HIV in Global Health and the SDGs
Alessandra Nilo, Brazil
Alessandra Nilo is a journalist, film director and screenwriter with an academic specialisation in communications and health. She is Co-founder and Executive Director of Gestos, an HIV and AIDS organisation located in Recife, Brazil. Nilo has worked to publicise the United Nations General Assembly Declaration of Commitment on HIV and AIDS as a tool to monitor and evaluate the implementation of national HIV policies. She developed the UNGASS-AIDS Forum platform in Brazil and has represented civil society in the Brazilian national delegations to the UN High Level Meetings on HIV. She is also the Regional Secretariat of the Latin American and Caribbean Council of AIDS Organizations (LACCASO) and represented Latin America and the Caribbean (LAC) at the Program Coordinating Board of UNAIDS from 2012-2014. She is currently co-leading the Women Won’t Wait campaign in Brazil, while serving on the Board of Directors of ABONG (Brazilian Association of Non-Governmental Organisations) and Action Aid Brazil. She is also a member of the High Level Task Force for the International Conference on Population and Development (ICPD).
Friday 22 July - Day 4: How do we get there?
Towards a New Treatment Era?: Translating Results from START and TEMPRANO to Clinical Practice
Serge Eholié, Ivory Coast
Serge Paul Eholié is a professor of Infectious and Tropical Diseases at Treichville University Teaching Hospital in Abidjan, Côte d’Ivoire. He is also a senior lecturer at the University Felix Houphouet Boigny Medical School in Abidjan, Côte d’Ivoire. Dr. Eholié received his medical degree from the university of Abidjan and later specialized in infectious and tropical diseases. He was trained in HIV management in France (Marseille and Paris) and has served as a trainer In HIV in several African countries. He is currently the deputy director of the National Agency for Research on AIDS and Hepatitis (ANRS) Research Centre of Abidjan, the President of the Réseau Africain des Praticiens Assurant la prise en charge des personnes vivant avec le VIH/SIDA (RESAPSI), and is the vice president of Alliance Francophone des Acteurs de la Santé contre le VIH (AFRAVIH). He co-chaired the WHO clinical guidelines developing group for the 2013 and 2015 guidelines. He is currently involved in research around HIV therapeutic strategies, HIV and hepatitis co-morbidities, HIV and non-communicable diseases, HIV and ageing, and Ebola therapeutic and vaccine trials.
Ending pediatric AIDS
Dorothy Mbori-Ngacha, UNICEF
Dr Dorothy Mbori-Ngacha is a medical epidemiologist with specialist training in paediatrics, infectious diseases and child health. She is currently Chief of the HIV Section at UNICEF Nigeria. Prior to this, she was the Senior HIV Specialist at UNICEF in the Eastern and Southern Africa Region, where her main focus was on Prevention of Mother to Child Transmission (PMTCT) and paediatric HIV. Other positions she has had held include Chair and Associate Professor in the Department of Paediatrics at the University of Nairobi, Affiliate Associate Professor in the Department of Epidemiology at the University of Washington and Deputy Director for Programmes for the US Centers for Disease Control and Prevention (CDC) Global AIDS Programme in Kenya. For her work in paediatric AIDS, Dr Mbori-Ngacha received the Elizabeth Glaser Pediatrics AIDS Foundation International Leadership Award in 2002.
Essential Medicines, IP and Access
Malebona Precious Matsoso, South Africa
Malebona Precious Matsoso was appointed Director General of the National Department of Health in South Africa in June 2010. Previously the Director of the Public Health, Innovation and Intellectual Property Programme at the World Health Organization, Matsoso was responsible for the implementation of the Global Strategy and Plan of Action on Public Health, Innovation and Intellectual Property. Matsoso has been a member of various advisory panels locally and internationally, with a primary focus on improving access to medicines. Prior to her international assignments, she was the Registrar of Medicines for the Medicines Control Council in South Africa and held several senior positions in the South African Government.
What’s New, What’s Next, What’s Ahead?
Carlos del Rio, Mexico
Since his days as a physician in training, Dr del Rio has worked to reduce the spread of HIV on multiple fronts—leading the National AIDS Program in his native Mexico, caring for patients at Grady Memorial Hospital, directing the NIH-sponsored HIV Prevention Trials Network at Emory University Rollins School of Public Health (Emory RSPH), advising US agencies on HIV prevention and care, and growing global capacity for HIV research. Dr del Rio, Hubert Professor and Chair of the Hubert Department of Global Health at Emory RSPH, also co-directs the Emory Center for AIDS Research and leads the Emory AIDS International Training and Research Programme.